ZLAB Stock Summary and Trading Ideas (Zai Lab Limited - American Depositary Shares | NASDAQ:ZLAB)

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

Zai Lab Limited - American Depositary Shares trades on the NASDAQ stock market under the symbol ZLAB.

As of February 6, 2026, ZLAB stock price climbed to $18.00 with 637,000 million shares trading.

ZLAB has a beta of 0.93, meaning it tends to be less sensitive to market movements. ZLAB has a correlation of 0.08 to the broad based SPY ETF.

ZLAB has a market cap of $2.02 billion. This is considered a Mid Cap stock.

Last quarter Zai Lab Limited - American Depositary Shares reported $116 million in Revenue and -$.33 earnings per share. This fell short of revenue expectation by $-28 million and missed earnings estimates by -$.04.

In the last 3 years, ZLAB traded as high as $44.34 and as low as $13.48.

The top ETF exchange traded funds that ZLAB belongs to (by Net Assets): IBB, CANC, SBIO, BBP, DFEM.

ZLAB has underperformed the market in the last year with a price return of -35.3% while the SPY ETF gained +15.1%. ZLAB has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -22.2% and -1.8%, respectively, while the SPY returned +3.3% and +0.2%, respectively.

ZLAB support price is $16.47 and resistance is $17.49 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ZLAB shares will trade within this expected range on the day.